Jean‐Charles Deybach

Institut d'Etudes Politiques de Paris — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index8.4kcitations696works8.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Porphyrin Metabolism and Disorders(160), Heme Oxygenase-1 and Carbon Monoxide(111), Neonatal Health and Biochemistry(76), Folate and B Vitamins Research(52), Metabolism and Genetic Disorders(50)

Publications189 total

Porphyrins and the porphyrias
Liver International·2024· 10 citedOpen Access
Exploring current and emerging therapies for porphyrias
Liver International·2024· 7 citedOpen Access
From chemistry to genomics: A concise history of the porphyrias
Liver International·2024· 7 citedOpen Access
Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors
European Radiology·2021· 4 cited
PRO2 REAL WORLD LONGITUDINAL HEALTHCARE RESOURCE UTILIZATION FOR PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP)
Value in Health·2020
Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria
Haematologica·2020· 23 citedOpen Access
Enquête PAI-France : prévalence des symptômes aigus et chroniques dans la porphyrie aiguë intermittente
La Revue de Médecine Interne·2019
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
Hepatology·2019· 158 citedOpen Access
Current and innovative emerging therapies for porphyrias with hepatic involvement
Journal of Hepatology·2019· 38 citedOpen Access
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias
Genetics in Medicine·2019· 23 citedOpen Access
EXPLORE : Étude prospective, multinationale de l’évolution naturelle des patients atteints de porphyrie hépatique aiguë avec des crises récurrentes
Revue Neurologique·2019
Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria
The American Journal of Human Genetics·2019· 27 citedOpen Access
Systemic Administered mRNA as Therapy for Metabolic Diseases
Trends in Molecular Medicine·2018· 6 cited
Explore : étude prospective, multinationale de l’évolution naturelle des patients atteints de porphyrie hépatique aiguë avec des crises récurrentes
La Revue de Médecine Interne·2018
Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword
Molecular Genetics and Metabolism·2018· 45 citedOpen Access
An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore: A Prospective, Multinational Natural History Study of Patients with AHP
Value in Health·2018· 8 cited
Trends in healthcare utilization in the United States and Europe associated with patient with acute hepatic porphyria with recurrent attacks in EXPLORE: A prospective, multinational natural history study of patients with acute hepatic porphyria
Journal of Hepatology·2018· 2 cited
EXPLORE: A prospective, multinational natural history study of patients with acute hepatic porphyria with recurrent attacks
Journal of Hepatology·2018· 26 citedOpen Access
Impact of acute hepatic porphyrias on quality of life and work loss: An analysis of EXPLORE natural history study
Journal of Hepatology·2018
Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver
Journal of Internal Medicine·2018· 115 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Hervé Puy(30), Laurent Gouya(21), Y Nordmann(21), Bernard Grandchamp(14), J. Lamoril(12), Hubert de Verneuil(9), Vasco Da Silva(8), Caroline Schmitt(8), Sharon D. Whatley(6), Carole Beaumont(6), Michael N. Badminton(5), George H. Elder(5), Saı̈d Lyoumi(5), Elisabeth I. Minder(5), Zoubida Karim(5), Sarah Ducamp(4), Anne-Marie Robréau(4), Sylvie Simonin(4), Cécile Ged(4), A. Anstey(3)